Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Other hematologic neoplasm 1Myeloid 1

Conditions

Thrombocytopenia 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia 1Chemotherapy-induced Thrombocytopenia 1

Interventions

eltrombopag 8romiplostim 5Cytarabine 4Filgrastim 3Etoposide 3Daunorubicin 3Carboplatin 3oprelvekin 2fludarabine phosphate 2avatrombopag 2Thrombopoietin 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Lenalidomide 2Interleukin-11 2Ifosfamide 2Doxorubicin 2Cyclosporine 2Busulfan 2sargramostim 1ofatumumab 1lusutrombopag 1leridistim 1bryostatin 1 1angiotensin I (1-7) 1alvocidib 1Vitamin E 1Vitamin B 12 1Vincristine 1Tranexamic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Thrombocytopenia × oprelvekin × Clear all
NCT01663441 2020-09-16

A Phase â…¢a Study of Genetically Modified Recombinant Human Interleukin-11

Beijing Northland Biotech. Co., Ltd.

Phase 3 Completed
62 enrolled
Classical hematology

Thrombocytopenia

NCT00493181 2012-02-20

Interleukin 11, Thrombocytopenia, Imatinib in Chronic Myelogenous Leukemia (CML) Patients

M.D. Anderson Cancer Center

Phase 2 Completed
8 enrolled 3 charts
Classical hematologyMyeloidOther hematologic neoplasm

Leukemia, Thrombocytopenia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡